UGAZ Nat Gas Leveraged ETF +5% in our Friday Trade
by Mike Paulenoff
July 1, 2017 • 12:00 AM EDT
Last week we noted our 5.6% trade in the SPDR S&P Biotech ETF (XBI). We continued to be bullish on the XBI, and had a target of 79-80.
This week the XBI met our target and then some, reaching 80.89 before closing the week at 77.18.
There's a risk down to the recent upside breakout in the 73-71 area at some point, which, if it contains the weakness, could provide the launchpad for a thrust towards 100 in the very big picture.
Another sector we follow closely is Natural Gas. On Tuesday of this week we told our members to watch for movement off of Wednesday's release of weekly Nat Gas inventories.
We noted that the release could trigger a downside stop-fest that presses Nat Gas back under 3.00, into the 2.90 area support, where my work argues in favor of establishing or adding new long positions ahead of upside potential again into the 3.30-3.40 target zone.
On Wednesday's release, Nat Gas initially popped to challenge June resistance at 3.10-3.11, but stalled there and a bit later in the session pivoted to the downside into a nosedive that violated nearest term support at 3.066.
As it dropped towards our preferred support area, we added a position in the VelocityShares 3x Long Natural Gas ETN (UGAZ) on Friday at 13.17. By the close, the UGAZ was at 13.82, giving us a +5% yield on our trade for the day.
Have a great weekend!
Mike Paulenoff is the author of MPTrader.com, a real-time diary of his technical analysis & trade alerts on
ETFs for precious metals, energy, currencies, and an array of equity indices and sectors, including international
markets, plus key ETF component stocks in sectors like technology, mining, and banking.
Sign up for a Free 7-day Trial!
More Top Calls From Mike
In his September 30th chart analysis for MPTrader members, Mike Paulenoff wrote bullishly about AMD, noting:
"AMD has piqued my interest technically because all of the price action off of its ATH at 122.38 (8/04) into the September lows at 99.51 (9/20) and 99.81 (9/29) has the right look of a complete, or nearly-completed correction of the prior major advance off of the 5/13 low at 72.50. As long as the 99.
MRNA's August downside reversal from a new all-time high (ATH) at 498.60 (8/10/21) to 349.00 (8/16/21) was just the first shot over the bow of a larger-developing corrective pattern and period.
Thus warned Mike Paulenoff to our members on the afternoon of August 16th, when, with MRNA trading at 363.
This past Monday, with Nike (NKE) poised to report earnings later in the week, Mike Paulenoff told MPTrader members that "NKE is vulnerable to a press into the 140-143 target zone either ahead of, or in reaction to, the earnings news."
NKE was trading at 161.75 at the time, and by the week's end the stock was 149.59, having hit a low of 148.
Back on August 18th, nearly two weeks ahead of ZM's (Zoom Video Communications) earnings report, Mike Paulenoff cautioned MPTrader members about the stock.
Mike wrote: "The price structure, which has pressed relentlessly lower (15%) since its 8/05 rally high at 404.35, is probing -- and trading below -- its 100 DMA, now at 345.67, and is considerably beneath its 200 DMA, now down-sloping at 367.20.
In our Top Call article a month ago, we told you about how Mike Paulenoff called AAPL's upside continuation, with the expectation that the stock could extend a little higher before upside exhaustion.
AAPL, indeed, went on to stair-step higher to reach a high of 157.26 high last week, overshooting the upper boundary of Mike's 153-156 projected high-zone by just 0.8%. It then proceeded to initiate the expected bout of weakness that accelerated to the downside this past Friday.